Maged 2018.
Trial name or title | Carbetocin versus rectal misoprostol for management of third stage of labor in women at low risk of postpartum hemorrhage |
Methods | Interventional (clinical trial) |
Participants | Women admitted for spontaneous, induced or augmented vaginal delivery and categorized as low risk for PPH |
Interventions | Carbetocin 100 mcg IV versus misoprostol 800 mcg PR |
Outcomes | Prevention of PPH after vaginal delivery and side effects |
Starting date | July 2, 2017 |
Contact information | Ahmed Maged, Cairo University |
Notes | Completed but no results posted |